Description
Rinvoq (upadacitinib) 15mg is a prescription, once-daily oral,
extended-release tablet used to treat Rinvoq 15mg tablet price moderate-to-severe chronic inflammatory conditions,
including rheumatoid arthritis, psoriatic arthritis, ankylosing Rinvoq 15mg tablet online spondylitis, and atopic dermatitis.
As a Janus kinase (JAK) inhibitor, it works by reducing inflammation and buy online Rinvoq 15mg tablet immune system activity.
Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Atopic dermatitis (severe eczema) Ulcerative colitis & Crohn’s disease
Usual dosage: One 15mg tablet taken once daily, regardless of meal administration. Dosage regimen: Take RINVOK exactly as prescribed. Take this medicine whole. Do not chew, cut or crush the tablet.
It has been demonstrated that upadacitinib suppresses the immune system, thus causing an increased chance of developing infections (including TB, shingles, bacterial/fungal infections, etc.) that are likely to become very dangerous or even lethal. Therefore, RINVOK is contraindicated for people suffering from active and/or diffuse infections.
In addition, before starting treatment with RinvoK, the patient will probably have to go through some tests performed to diagnose TB.
RINVOK is an RX drug used for RA patients whose condition is moderate or severe, having received and failed 1 or several TNF blockers treatments. In such cases, a physician is likely to prescribe upadacitinib as a next step of treatment.
Upadacitinib is used to treat moderate to severe active rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis (inflammation of vertebrae joints),
and polyarticular juvenile idiopathic arthritis (a type of childhood arthritis that affects many joints) in patients who have IT.
